Abstract
Different delivery systems are currently used in therapy. They have the advantage of protecting the active substance from rapid clearance and avoiding toxic side effects. Among the many carrier systems proposed12, RBCs have many desirable properties: they are naturally biodegradable and may stay in circulation over prolonged periods of time11,25; RBCs are easily obtainable and large amounts of material can be entrapped in a small volume of cells by hypotonic dialysis; autologous cells elicit little or no immune response7,16,20.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
F.J. Alvarez, A. Herráez, J.C. Murciano, J. A. Jordán, J.C. Díez, and M.C. Tejedor, In vivo survival and organ uptake of loaded carrier rat erythrocytes. J. Biochem. 120:286 (1996).
F.J. Alvarez, A. Herráez, and M.C. Tejedor, Fluorescence analysis of carrier rat and human erythrocytes loaded with FITC-dextran. Cytometry 24:181 (1996).
F.J. Alvarez, A. Herráez, M.C. Tejedor, and J.C. Díez, Behaviour of isolated rat and human red blood cells upon hypotonic-dialysis encapsulation of carbonic anhydrase and dextran. Biotechnol. Appl. Biochem. 23:173(1996).
U. Benatti, E. Zocchi, M. Tonetti, L. Guida, C. Polvani, and A. De Flora, Enhanced antitumor activity of adriamycin by encapsulation in mouse erythrocytes targeted to liver and lungs. Pharmacol. Res. 21:27 (1989).
L. Chiarantini, A. Antonelli, G. Serafini, A. Fraternale, and M. Magnani, In vivo survival and in vitro phagocytosis of engineered erythrocytes. Adv. Biosci. 92:83 (1994).
L. Chiarantini, J. Johnson, and J.R. DeLoach, Optimized recirculation survival of mouse carrier erythrocytes. Blood Cells 17:607 (1991).
A. De Flora, E. Zocchi, L. Guida, C. Polvani, and U. Benatti, Conversion of encapsulated 5-fluoro-2′-deoxyuridine 5′-monophosphate to the antineoplastic drug 5-fluoro-2′-deoxyuridine in human erythrocytes. Proc. Nat. Acad. Sci. USA 85:3145 (1988).
J.R. DeLoach, K. Andrews, W. Satterfield, and M. Keeling, Intraperitoneal administration of carrier erythocytes in dogs: an improved method for delivery of L-asparaginase. Biotechnol. Appl. Biochem. 12:331 (1990).
J.R. DeLoach, K. Andrews, and C.L. Sheffield, Encapsulation of interleukin-2 in murine erythrocytes and subsequent deposition in mice receiving a subcutaneous injection. Biotechnol. Appl. Biochem. 10:183 (1988).
J.R. DeLoach and R.E. Droleskey, Survival of murine carrier erythrocytes injected via peritoneum. Comp. Biochem. Physiol. A 84:447 (1986).
J.R. DeLoach and R.E. Droleskey, Preparation of ovine carrier erythrocytes: their action and survival. Comp. Biochem. Physiol. A 84:441 (1986).
P.K. Gupta, Drug targeting in cancer chemotherapy: a clinical perspective. J. Pharm. Sci. 79:949 (1990).
J.A. Jordán, R.B. Moyes, R. Droleskey, J.C. Diez, J. Luque, and J.R. DeLoach, In vitro and in vivo evaluation of BS3 and DTSSP crosslinked erythrocytes. Adv. Biosci. 92:17 (1994).
G. Lee, T.M. Delohery, Z. Ronai, P.W. Brandt-Rauf, M.R. Pincus, R.B. Murphy, and I.B. Weinstein, A comparison of techniques for introducing macromolecules into living cells. Cytometry 14:265 (1993).
J. Luque, M.I. Garín, S. Sanz, P. Ropero, and M. Pinilla, Properties of hypotonized, crosslinked and crosslinked-permeabilized rat erythrocytes as potential carrier systems. Adv. Exp. Med. Biol. 326:81 (1992).
M. Magnani, G. Serafini, and V. Stocchi, Hexokinase type I multiplicity in human erythrocytes. Biochem. J. 254:617(1988).
M. Morrison, A.W. Michaels, D.R. Phillips, and S. Choi, Life span of erythrocyte membrane protein. Nature 248:763 (1974).
M.T. Pérez, F.J. Alvarez, A.I. García-Pérez, L. Lucas, M.C. Tejedor, and P. Sancho, Heterogeneity of hypo-tonically loaded rat erythrocyte populations as detected by counter-current distribution in aqueus polymer two-phase systems. J. Chromatogr. B 677:45 (1996).
E. Pitt, C.M. Johnson, D.A. Lewis, D.A. Jenner, and R.E. Offord, Encapsulation of drugs in intact erythrocytes and intravenous delivery system. Biochem. Pharmacol. 32:3359 (1983).
L. Rossi, M. Bianchi, A. Fraternale, and M. Magnani, Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes. Adv. Exp. Med. Biol. 326:183 (1992).
M.C. Tejedor, C.E. Alvarez, F.J. Alvarez, A. Herráez, and J. Luque, Comparative encapsulation at different hypotonie pressures in human and rat erythrocytes. Adv. Biosci. 92:73 (1994).
M. Tonetti, C. Polvani, E. Zocchi, L. Guida, U. Benatti, P. Biassoni, F. Romei, A. Guglielmi, C. Aschete, A. Sobrero, and A. De Flora, Liver targeting of autologous erythrocytes loaded with doxorubicin. Eur. J. Cancer 27:947 (1991).
E. Zocchi, L. Guida, U. Benatti, M. Canepa, L. Borgiani, T. Zanin, and A. De Flora, Hepatic or splenic targeting of carrier erythrocytes: a murine model. Biotechnol. Appl. Biochem. 9:423 (1987).
E. Zocchi, M Tonetti, C. Polvani, L. Guida, U. Benatti, and A. De Flora, In vivo liver and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes. Biotechnol. Appl. Biochem. 10:555(1988).
L. Zolla, G. Lupidi, M. Marcheggiani, G. Falcioni, and M. Brunori, Encapsulation of proteins into human erythrocytes: a kinetic investigation. Biochim. Biophys. Acta 1024:5 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Alvarez, F.J. et al. (1997). Rat Carrier Erythrocytes Circulate and Arrive to Organs. In: Sprandel, U., Way, J.L. (eds) Erythrocytes as Drug Carriers in Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0044-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0044-9_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0046-3
Online ISBN: 978-1-4899-0044-9
eBook Packages: Springer Book Archive